Stay updated with breaking news from Nasdaq Spro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spero Therapeutics, Inc. (NASDAQ:SPRO – Free Report) – Investment analysts at HC Wainwright upped their Q2 2023 earnings per share (EPS) estimates for shares of Spero Therapeutics in a research note issued on Thursday, July 20th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.28) for the […]
Bourgeon Capital Management LLC grew its stake in shares of Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Rating) by 95.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 25,600 shares of the company’s stock after buying an additional 12,500 shares during the period. Bourgeon Capital […]
Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Rating) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 974,400 shares, a decline of 32.8% from the April 30th total of 1,450,000 shares. Based on an average daily trading volume, of 573,600 shares, the days-to-cover ratio […]
Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Rating) saw a large drop in short interest in the month of April. As of April 30th, there was short interest totalling 1,450,000 shares, a drop of 21.6% from the April 15th total of 1,850,000 shares. Based on an average daily volume of 576,200 shares, the days-to-cover ratio is […]
Spero Therapeutics, Inc. (NASDAQ:SPRO – Get Rating) saw a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 1,450,000 shares, a decrease of 21.6% from the April 15th total of 1,850,000 shares. Based on an average trading volume of 576,200 shares, the days-to-cover ratio is […]